TiGenix NV
DelistedCIK 1581987fmd_0X54A1RCYDXPK5S1HXHXATJ1N8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2017, 3 periods
| Line item | FY2015 | FY2016 | FY2017 |
|---|---|---|---|
| Research and development | 20 | 21 | 44 |
| Operating income | (24) | (3) | (53) |
| Interest expense | 13 | 7 | 22 |
| Income before taxes | (36) | 2 | (75) |
| Income tax expense | (1) | (2) | 0 |
| Net income from continuing operations | (35) | 4 | (75) |
| Net income | (35) | 4 | (75) |